Ambulatory Care Pharmacy Forum of NC Annual Meeting 2021

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

The Ambulatory Care Pharmacy Forum of North Carolina is a network for and led by ambulatory clinical pharmacists with an ongoing goal of providing networking, collaboration, and educational opportunities for likeminded pharmacists in North Carolina with an emphasis on practical ambulatory care topics and unmet public health needs.

In addition to providing networking opportunities for ambulatory care pharmacist, this application-based CPE activity will provide the pharmacist with clinical practice updates on a variety of topics.

For more information on Ambulatory Care Pharmacy Forum of NC, Click on: www.AmbulatoryCarePharmacyForum.com

Download conference brochure for full description including agenda, objectives and speakers.

This conference will be offered as a live stream webinar.

Live Webinar Information
This webinar will be broadcast with Zoom. Instructions to join the webinar will be emailed prior to the event. Please go to our live webinar requirements page for more information and to test the computer/device and network prior to the event.


Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE#0046-9999-21-009-L01-P (Pharmacist) provides 6.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**


CONFERENCE AGENDA (please check back for updates in agenda times):

8:30 am -8:45 Welcome and Introductions

8:45 am – 9:45 am To Treat or Not to Treat: Management of Dyslipidemia in Older Adults
Kim Nealy, PharmD, BCPS, CDCES, CPP

9:45 am - 9:50 am BREAK

9:50 am – 10:50 am The Role of SGLT2 Inhibitors in CKD
Donald S Nuzum, PharmD, BCACP, BC-ADM, CDE, CPP and
Alaina Olenik, PharmD, BCACP, CDCES, CPP

10:50 am - 10:55 am BREAK

10:55 am – 11:55 am Tobacco/Nicotine Abuse – A Comprehensive Approach for Preventive Wellness
Pete Koval, PharmD, BCPS, CPP

11:55 am -12:15PM Lunch

12:15 pm - 1:15 PM Exhibitors

1:15 PM – 2:15 PM Update on the Treatment of Depression in Primary Care
Chris Dolder, PharmD, BCPS

2:15 PM - 2:20 PM BREAK

2:20 PM to 3:20 PM Breathe Easier: Updates in Asthma Management
Andy Woods, PharmD, BCPS

3:20 PM - 3:25 PM BREAK

3:25-4:25 Clinical Pearls for Adapting to the Virtual World
Moderator: Erika Peterfy, PharmD, CDE, BCACP and Nick Wilkins, PharmD, BCPS, CDCES, CPP
Panelist: Shay Phillips and Kristie Clark

4:25 PM - 4:30 PM Wrap Up

Objectives

• Discuss literature and guideline recommendations for management of dyslipidemia in older adults (Nealy)
• Identify candidates for pharmacologic intervention for dyslipidemia (Nealy)
• Outline utility of medications available for the treatment of dyslipidemia in older adults (Nealy)
• Select evidence-based treatment plans for older adults with dyslipidemia (Nealy)
• Summarize SGLT2 inhibitor CVOT, HF and CKD data (Nuzum/Olenik)
• Identify patients with or without T2DM who may benefit from SGLT2inhibitor therapy in the presence of CDK(Nuzum/Olenik)
• Select an appropriate medication regimen given a patient case (Nuzum/Olenik)
• Identify efficient strategies for eliciting and evoking change in patients interested in tobacco cessation. (Koval)
• Select and implement alternative drug therapy strategies for patients unsuccessful with tobacco cessation monotherapy. (Koval)
• Summarize treatment guidelines for the pharmacologic treatment of depression (Dolder)
• Summarize properties of newer antidepressants and describe their potential role in the treatment of depression (Dolder)
• Describe augmentation strategies for the treatment of depression (Dolder)
• Discuss new GINA recommendations regarding asthma reliever medications (Woods)
• Identify an appropriate patient care plan that incorporates up-to-date practice recommendations through a patient case (Woods)
• Describe commonly available technologies to assist in delivering clinical pharmacy services.(Panel)
• Discuss the different platforms available to gather relevant clinical data from patients remotely.(Panel)
• Summarize numerous key factors and ideas to engage virtual learners. (Panel)
• Identify several available avenues for billing clinical services via remote and telehealth work.(Panel)

Sessions